Here are the S-1 registration statements from Klotho Neurosciences, Inc. (KLTO) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow KLTO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KLTO filings page.
Klotho Neurosciences, Inc. has filed a prospectus covering the resale of up to 35,000,000 shares of its common stock. Up to 34,000,000 of these shares are issuable upon conversion of newly created Series C Convertible Preferred Stock sold in a private placement for an aggregate purchase price of $15,000,000, with an additional 1,000,000 existing shares registered for an early investor.
The company will not receive any proceeds when the selling stockholders resell these shares. The Series C Preferred is convertible at $0.44 per share, subject to ownership limits and Nasdaq rules, and shares outstanding were 72,536,722 as of December 2, 2025. Klotho’s stock trades on the Nasdaq Capital Market under the symbol KLTO, where the average of the high and low prices on December 2, 2025 was $0.43 per share.